Edition:
United Kingdom

Agios Pharmaceuticals Inc (AGIO.OQ)

AGIO.OQ on NASDAQ Stock Exchange Global Select Market

41.36USD
4:22pm BST
Change (% chg)

$-0.48 (-1.15%)
Prev Close
$41.84
Open
$41.62
Day's High
$42.03
Day's Low
$41.09
Volume
25,822
Avg. Vol
193,591
52-wk High
$85.00
52-wk Low
$38.71

About

Agios Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group of over 600 rare genetic diseases caused by mutations, or defects, of single metabolic genes. The Company's cancer product candidates are... (more)

Overall

Beta: 2.15
Market Cap(Mil.): $2,670.19
Shares Outstanding(Mil.): 58.71
Dividend: --
Yield (%): --

Financials

  AGIO.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -5.99 -- --
ROI: -40.81 7.52 12.69
ROE: -46.88 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates